Insulin-like growth factor-I treatment to enhance renal function in advanced chronic renal failure

Renal Failure

Volumn 20, Issue 2, 1998, Pages 349-356

  Fervenza, Fernando C ^b   Friedlaender, Michael M ^b   Ike, John O ^b   Rabkin, Ralph ^a  

^a VA PALO ALTO HEALTH CARE SYSTEM   (United States)

^b NONE

Author keywords

Chronic renal failure; Insulin like growth factor

Indexed keywords

4 AMINOHIPPURIC ACID; CREATININE; INULIN; SOMATOMEDIN BINDING PROTEIN 2; SOMATOMEDIN BINDING PROTEIN 3; SOMATOMEDIN C;

4 AMINOHIPPURIC ACID CLEARANCE; ADULT; ARTICLE; CHRONIC KIDNEY DISEASE; CLINICAL ARTICLE; CONTROLLED STUDY; CREATININE CLEARANCE; DRUG BLOOD LEVEL; DRUG CLEARANCE; DRUG DISTRIBUTION; GLOMERULUS FILTRATION RATE; HUMAN; INULIN CLEARANCE; MALE; NITROGEN BALANCE; PRIORITY JOURNAL; SUBCUTANEOUS DRUG ADMINISTRATION;

EID: 0031924079     PISSN: 0886022X     EISSN: None     Source Type: Journal    
DOI: 10.3109/08860229809045121     Document Type: Article

References (28)

1. Bosch JP: Renal reserve: A functional view of glomerular filtration rate. Semin Nephrol 15:381-385, 1995.
2. Meyer-Lehnert H, Bayer T, Predel H-G, Glänzer K, Kramer HJ: Effects of atrial natriuretic peptide on systemic and renal hemodynamics and renal excretory function in patients with chronic renal failure. Klin Woehenschr 69:895-903, 1991.
3. Windus DW, Stokes TJ, Morgan JR, Klahr S: The effects of atrial peptide in human with chronic renal failure. Am J Kidney Dis 13:477-484, 1989.
4. De Nicola L, Bellizzi V, Cianciaruso B, Minutolo R, Colucci G, Balletta M, Fuiano G, Conte G: Pathophysiologjcal role and diuretic efficacy of atrial natriuretic peptide in renal patients. J Am Soc Nephrol 8:445-455, 1997.
5. Palla R, Parrini M, Panichi V, Andreini B, De Pietro S, Migliori M, Bianchi AM, Giovannini L, Bertelli A, Bertolli AAE, Gazzetti P: Acute effects of calcitonin gene related peptide on renal haemodynamics and renin and angiotensin II secretion in patients with renal disease. Int J Tiss Reac 17:43-49, 1995.
6. Christiansen SJ, Gammelgaard J, Ørskov H, Andersen AR, Telmer S, Parving HH: Kidney function and size in normal subjects before and during growth hormone administration for one week. Eur J Clin Invest 11:487-490, 1981.
7. Trachtman H, Futterweit S, Schwob N, Maesaka S, Valderrama B: Recombinant human growth hormone exacerbates chronic puromycin aminonucleosides nephropathy in rats. Kidney Int 44:1281-1288, 1993.
8. Tönshoff B, Tönshoff C, Mehls O, Pinkowski J, Blum WF, Heinrich U, Stover B, Gretz N: Growth hormone treatment in children with preterminal chronic renal failure: No adverse effect on glomerular filtration rate. Eur J Pediatr 151:601-607, 1992.
9. Maxwell H, Nair DR, Neil Dalton R, Rigden SPA, Rees L: Differential effects of recombinant human growth hormone on glomerular filtration rate and renal plasma flow in chronic renal failure. Pediatr Nephrol 9: 458-463, 1995.
10. Haffner D, Zacharewicz S, Mehis O, Heinrich U, Ritz E: The acute effect of growth hormone on GFR is obliterated in chronic renal failure. Clin Nephrol 32:266-269, 1989.
11. Feld S, Hirschberg R: Growth Hormone, the insulin-like growth factor system and the kidney. Endocr Rev 17:423-480, 1996.
12. Hirschberg R, Brunori G, Kopple JD, Guler H-P: Effects of insulin-like growth factor 1 on renal function in normal men. Kidney Int 43:387-397, 1993.
13. O'Shea MH, Miller SB, Hammerman MR: Effect of IGF-I on renal function in patients with chronic renal failure. Am J Physiol 264:F917-922, 1993.
14. Miller SB, Moulton M, O'Shea M, Hammerman MR: Effects of IGF-I on renal function in end-stage chronic renal failure. Kidney Int 46:201-207, 1994.
15. Shamir E, Peng S, Fouque D, Kopple JD: Effect of insulin-like growth factor (IGF-I) on nitrogen balance in malnourished CAPD patients. (abstract) J Am Soc Nephrol 6:587, 1995.
16. Jones JI and Clemmons DR: Insulin-like growth factors and their binding proteins: biologic actions. Endocrine Review 16:3-34, 1995.
17. Blum WF, Ranke MB, Kietzmann K, Tonshoff B, Mehls O: Growth hormone resistance and inhibition of somatomedin activity by excess of insulin-like growth factor binding protein in uraemia. Pediatr Nephrol 5:539-544, 1991.
18. Fouque D, Peng SC, Kopple JD: Impaired metabolic response to recombinant insulin-like growth factor-1 in dialysis patients. Kidney Int 7:876-883, 1995.
19. Ike JO, Fervenza FC, Hoffman AR, Yeh I, Hintz RL, Liu F, Rabkin R; Early experience with extended use of insulin-like growth factor-1 in advanced chronic renal failure. Kidney Int 51:840-849, 1997.
20. Rabkin R, Fervenza PC, Maidment H, Ike J, Hintz R, Lin F, Bloedow DC, Hoffinan AR, Gesundheit N: Pharmacokinetics of insulin-like growth factor-1 in advanced chronic renal failure. Kidney Int 49:1134-1140, 1996.
21. Fouque D, Peng SC, Kopple JD: Pharmacokinetics of recombinant human insulin-like growth factor-1 in dialysis patients. Kidney Int 47:869-875, 1995.
22. Liu F, Powell DR, Hintz RL: Characterization of insulin-like growth factor-binding proteins in human serum from patients with chronic renal failure. J Clin Endocrinol Metab 70:620-628, 1990.
23. Clemmons DR: Insulin-like growth factor I as an anabolic agent in catabolic states. Ann Int Med 120:596-597, 1994.
24. Kupfer SR, Underwood LE, Baxter RC, Clemmons DR: Enhancement of the anabolic effects of growth hormone and insulin-like growth factor 1 by use of both agents simultaneously: J Clin Invest 91:391-396, 1993.
25. Moses AC, Young SCJ, Morrow LA, O'Brien M, Clemmons DR: Recombinant human insulin-like growth factor I increases sensitivity and improves glycemic control in type II diabetics. Diabetes 45:91-100, 1996.
26. Feld SM, Hirschberg R, Artishensky A, Nast C, Adler SG: Insulin-like growth factor I induces mRNA and secretion of collagen: Kidney Int 48:45-51, 1995.
27. Doi T, Striker LJ, Quaiffe C, Conti FG, Palmiter R, Behringer R, Brinster R, Striker GE: Progressive glomerulosclerosis develops in transgenic mice chronically expressing growth hormone and growth hormone releasing factor but not insulin-like growth factor-1. Am J Pathol 131:398-403, 1988.
28. Trachatman H, Maesaka J, Futerwert S, Schwab N, Chan MA, Valderrama E, Chan JCM, Chan W. The effect of recombinant human insulin-like growth factor-I on chronic puromycin aminoglycoside nephropathy in rats. Pediatric Res 39:13-19, 1996.